Narcolepsy Sleep Disorders

Download PDF

Recent Publications on Narcolepsy Sleep Disorders:
MX2 gene expression tends to be downregulated in subjects with HLA-DQB1*0602. OBJECTIVE: There is a close association between narcolepsy and the human...	18th July, 2008	Sleep Disorders Project, Department of Sleep Disorders Research, Tokyo	Sleep. 2008 May 1;31(5):749-51.
Abnormal sleep and sleepiness in Parkinson's disease. PURPOSE OF REVIEW: Sleep problems are frequent and disabling in patients...	9th July, 2008	Sleep Disorders Unit, Pitie-Salpetriere Hospital, Assistance	Curr Opin Neurol. 2008 Aug;24(4):472-7. DOI Direct Link
Armodafinil for excessive daytime sleepiness. Armodafinil is the (R)-enantiomer of the wakepromoting compound modafinil...	4th July, 2008	Professor of Psychiatry and Behavioral Sciences, Director, Sleep and	Drugs Today (Barc). 2008 Jun;44(6):395-414. DOI Direct Link
Sleep disturbances in dialysis patients. Sleep disorders are common in dialysis patients. Insomnia is reported in...	2nd July, 2008	Sleep Disorder Center, Neurology and Clinical Neurophysiology, Santa Maria	J Nephrol. 2008 Mar-Apr;21 Suppl 13:S66-70.
Sodium oxybate: efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy. Sodium oxybate is the sodium salt of gamma- hydroxybutyrate, an endogenous...	1st July, 2008	Medical Information Department, Prous Science, Barcelona, Spain.	Drugs Today (Barc). 2008 Mar;44(3):197-204. DOI Direct Link
→View more research publications.

Narcolepsy Sleep Disorders Patents:
US Patent No.	Title
7396654	Neural proteins as biomarkers for traumatic brain injury
6894062	Quinoline derivatives
6822100	Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
6780889	Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
6777437	Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Narcolepsy Sleep Disorders scientists - we have details of around 249 individuals working on Narcolepsy Sleep Disorders .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.